<DOC>
	<DOCNO>NCT01577121</DOCNO>
	<brief_summary>To demonstrate indomethacin associate conventional treatment preterm labor useful delay delivery improve neonatal morbimortality woman preterm labor high risk intraamniotic inflammation</brief_summary>
	<brief_title>Evaluation Use Indomethacin Co-treatment Women With Preterm Labor High Risk Intraamniotic Inflammation</brief_title>
	<detailed_description>Randomised patient would assign receive indomethacin either placebo oral use ( 50 mg every 6 hour 5 day ) evaluate efficacy indomethacin complementary treatment increase gestational age delivery woman admit preterm labor intact membrane high risk intraamniotic inflammation , define gestational age admission le 28.0 week woman 28-32.0 week sonographic cervical length le 15 mm</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<criteria>pregnant woman preterm labor admit hospital treat tocolysis pregnant woman less 28.0 woman 28.0 32.0 sonographic cervical length &lt; 15 mm single pregnancy normal amniotic fluid normal arterial ductus Age 18 year previous use indomethacin index pregnancy chorioamnionitis , preterm prelabour rupture membrane fetal maternal pathology could responsible iatrogenic preterm delivery . oligohydramnios allergy NSAID previous history gastrointestinal bleeding use NSAID contraindicate adherence study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Preterm labor</keyword>
</DOC>